[CUE] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 26.59%
YoY- 44.34%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 1,075 900 1,049 984 1,055 370 331 119.46%
PBT -10,833 -12,818 -8,918 -6,990 -9,109 -11,267 -10,796 0.22%
Tax 618 -203 -1 -99 413 -114 -825,000 -
NP -10,833 -12,818 -8,918 -6,990 -9,522 -11,267 -11,621 -4.57%
Tax Rate - - - - - - - -
Total Cost 11,908 13,718 9,967 7,974 10,577 11,637 11,952 -0.24%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -1,007.72 -1,424.22 -850.14 -710.37 -902.56 -3,045.14 -3,515.18 -56.55%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.38 -0.48 -0.37 -0.31 -0.46 -0.54 -0.58 -24.58%
EPS Diluted -0.38 -0.48 -0.37 -0.31 -0.46 -0.54 -0.56 -22.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.